I was able to interview Prasad Sristi, CEO of Mindprint Solutions. Mindprint helps CRO’s efficiently run their businesses by integrating various layers of software in order to allow the CRO’s to focus on their core competency: drug discovery, development and clinical trial management. Prasad shares some of the insider knowledge with regards to how CRO’s negotiate their budgets with Sites, what business activities generate the most profit for them and we even get into the topic of remote monitoring. This was one of the better interviews I have conducted in some time as the behind the scenes insight into how a cro operates was valuable. I hope you find some of the findings helpful from this interview!
Well this is a first for me! I got word from one of my research clinics that Medicare called them demanding the names and contact information for all of the study participants in a particular study protocol as they were making sure that the study Sponsor (Pharmaceutical company) will pay for the costs associated with medical bills and hospital stays that patients incurred and Medicare covered that were related to clinical trial adverse events and serious adverse events. This may be a game changer going forward for our industry as there will probably be a requirement to invoice the study Sponsor for all medical bills associated with adverse events and serious adverse events. Should your clinic even comply with Medicare and potentially violate HIPAA? I am not a lawyer but will get one on the show very soon to discuss the legal implications of this. Stay tuned!
I get questions and sometimes, even long-winded rants, from research clinics complaining that their Principal Investigators are demanding too much money for their services or are otherwise being unrealistic about what they should be making. In this video I address this issue, surprisingly for the first time, and get into some of the specifics for how different research clinics are set up and also how they negotiate with their PI’s. Hope you enjoy!
Listen to this episode
I interview Barry Werth, author of The Antidote and Billion Dollar Molecule. I am currently reading his latest book, The Antidote, and I describe it as the Moneyball for Biotechs. In this interview, Barry and I discuss his two books, as well as the entire drug development process and even get into some of the guerilla marketing tactics that Vertex biotech, the star of the books, used in order to raise awareness about itself and some of the medical conditions that their researchers were working on.
In this wildly unstructured interview with guest guru, attorney and pharmacist Darshan Kulkarni, we dive into a wide variety of topics including how to possibly invest in and fund your own clinical trial, how research clinics are paid, what factoring means when it comes to your budget planning and much more.
Share your thoughts, questions, concerns at email@example.com and I will follow up with you!
In this week’s podcast/video, I get into a whole lot of viewer questions which span a broad variety of clinical research topics. One viewer asked the best way for a foreign medical doctor to get their foot inside the clinical trial industry, another asked how they can get compensated for a study that will be ongoing for more than 5 years, one asked about risk-based monitoring, yet another asked about starting a new research clinic and the list goes on and on! First of all, thank you guys for watching and sending me your questions. Secondly, I hope you find this blog post informative. Last but not least, keep the questions coming!